Walleye Capital’s Darling Ingredients DAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.01M Buy
49,500
+34,700
+234% +$2.18M ﹤0.01% 2425
2026
Q2
$808K Buy
14,800
+9,300
+169% +$555K ﹤0.01% 2308
2026
Q1
$340K Sell
5,500
-11,000
-67% -$542K ﹤0.01% 2974
2025
Q4
$594K Sell
16,500
-12,500
-43% -$423K ﹤0.01% 2847
2025
Q3
$895K Buy
29,000
+2,500
+9% +$83.5K ﹤0.01% 2175
2025
Q2
$1.01M Buy
26,500
+14,100
+114% +$464K ﹤0.01% 2051
2025
Q1
$387K Sell
12,400
-3,300
-21% -$115K ﹤0.01% 2764
2024
Q4
$529K Sell
15,700
-10,200
-39% -$386K ﹤0.01% 2929
2024
Q3
$962K Sell
25,900
-21,300
-45% -$803K ﹤0.01% 2686
2024
Q2
$1.73M Buy
47,200
+30,200
+178% +$1.25M ﹤0.01% 2246
2024
Q1
$791K Sell
17,000
-22,400
-57% -$986K ﹤0.01% 2801
2023
Q4
$1.96M Buy
39,400
+8,700
+28% +$395K ﹤0.01% 1792
2023
Q3
$1.6M Buy
30,700
+300
+1% +$18.7K ﹤0.01% 1898
2023
Q2
$1.94M Buy
+30,400
New +$1.85M 0.01% 1359
2022
Q4
– Sell
-1,200
Closed -$79K – 3269
2022
Q3
$79K Buy
+1,200
New +$83.7K ﹤0.01% 2500

Other funds holding DAR

Walleye Capital's DAR Position: Q3 2026 in Review

Walleye Capital increased its Darling Ingredients (DAR) stake by 33% in Q3 2026, buying an estimated $9.6M and bringing the position to 623,808 shares worth $37.9M. The position accounts for 0.03% of the portfolio, ranked #494.

Walleye Capital first reported a position in DAR in Q3 2019 and has held it in 19 quarters since. 512 funds tracked by Wall St. Rank hold DAR as of Q3 2026.

  • Walleye Capital held 623,808 shares of Darling Ingredients worth $37.9M as of Q3 2026.
  • Walleye Capital bought 153,283 Darling Ingredients shares in Q3 2026, an estimated $9.6M.
  • Darling Ingredients made up 0.03% of Walleye Capital's portfolio in Q3 2026, its #494 holding.
  • Walleye Capital first reported a position in Darling Ingredients in Q3 2019 and has held it in 19 quarters since.
  • 512 funds tracked by Wall St. Rank held Darling Ingredients as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.